Elise Evers | Senior Consultant
Initiate

Elise Evers, Senior Consultant, Initiate

Elise has five years of consultancy experience as a health economist and in HTA strategy in various therapeutic areas, including rare pediatric diseases. She has extensive expertise in economic modelling and preparing comprehensive reimbursement  submission dossiers for HTA bodies across the globe. Her background in health economics positions her to deliver impactful evidence to support access for innovative therapies. Elise holds an MSc in Health Economics from the University of York.

Appearances:



Day 1 - Tuesday 28 October @ 14:40

Challenges of Late onset Rare diseases – recommendations from the COLLABORATE Consensus Paper From Complexity to Clarity: Overcoming Reimbursement Challenges for Orphan Drugs

Session led by: Initiate Consultancy
last published: 23/Oct/25 13:15 GMT

back to speakers

Get involved at World Orphan Drug Congress Europe 2025

 

 

TO SPONSOR


Steph Scanlon

Steph.Scanlon@terrapinn.com

 

TO SPEAK


Abdu Kauroo
Abdu.Kauroo@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.